June 17, 2021
Nephron Research Expands, Adds Health Policy Team
June 14, 2021
Nephron Adds to Physician Enablement Coverage with Cano Health Initiation
May 25, 2021
Protected: Nephron Biopharma End Market Review Replay
May 21, 2021
Protected: Nephron Expert Series: Bioprocessing Expert Howard Levine – May 18th
May 20, 2021
Meehan’s Biopharma Update: Strong Backdrop for Tools & the CDMOs
May 14, 2021
Nephron Research Specialty Market Model 2021-2025
May 7, 2021
Nephron Research Liquid Biopsy Symposium – June 16th, 2021
March 30, 2021
Last Week’s CAH Upgrade More About Earnings Power Than Catalysts
March 19, 2021
Exit, Pursued by a Bear
March 16, 2021
Protected: Video Replay: Liquid Biopsy Initiations: EXAS & GH
March 12, 2021
Protected: Nephron Expert Series: Dr. Joel Brill – Early Cancer Detection LBx Payor Discussion
March 9, 2021
Protected: Nephron Expert Series: AGBT 2021 Recap w/ Niall Lennon
February 23, 2021
Protected: Telehealth Initiation Conference Call – 02/23/21
February 23, 2021
Telehealth Must Retool Post Pandemic: Initiating Coverage of TDOC and AMWL
February 17, 2021
COVID-19 Dx: Both Cases and Testing Continue to Moderate… What’s Next?